Bringing personalized medicine to reproductive health
Offer the test at your clinic

The world’s first multigene panel test for

a woman's reproductive health and fertility

The Fertilome test reveals genetic factors that are associated with some of the most common reproductive conditions in women.

Defining a new category of genetic tests

Unlike carrier screening tests, which look at the health risks for a baby, the Fertilome test reveals genetic risk factors related to reproductive conditions that may affect a woman's ability to conceive.

How the Fertilome test can work for you

By revealing genetic risk factors, the Fertilome test enables more refined diagnoses and treatment decisions than physical examinations or existing diagnostic tests alone. Using the genetic test can help you frame conversations around reproductive health and family building as a proactive journey.

Identify subclinical factors

Refine treatment plans

Counsel women with family history

Counsel egg freezing candidates

Guide targeted lifestyle counseling

The science behind our test

The Fertilome test identifies 49 variants in 32 genes associated with a spectrum of female reproductive conditions. The Fertilome panel was developed through a systematic literature review and statistical meta-analysis.

Take the next step

The Fertilome genetic test requires a blood or saliva sample, and sample collection kits can be ordered by a physician. The test is available in all U.S. states. and billed directly to the patient. The Fertilome genetic test is a laboratory developed test run by Celmatix Clinical Laboratories.2

For physicians

Interested in offering the Fertilome test at your practice? Contact our team today.

For patients

Interested in asking your provider about the Fertilome test? Download a discussion guide to share with your physician for ordering.

1. les/2657/current_clinical_validity_classi cations.pdf

2. The Fertilome® test was developed and its performance characteristics determined by Celmatix Clinical Laboratories, a laboratory regulated under the Clinical Laboratory Improvement Amendments (CLIA) as qualified to perform high-complexity clinical testing and the test has been analytically validated in accordance with CLIA standards and is permitted by the New York State Department of Health in Molecular Genetics. The Fertilome test has not been cleared or approved by the U.S. Food and Drug Administration (FDA). The FDA does not require this test to go through premarket FDA review. The Fertilome test is not a diagnostic test. The test is available in all 50 states.

Interested in taking a Fertilome test?